Home›Stock Screener›Eris Lifesciences›Quarterly Results

Eris Lifesciences Quarterly Results

Latest Quarter Net Profit
₹187 Cr
QSept 2026
Quarterly Results

Eris Lifesciences quarterly results. In Sept 2026, Eris Lifesciences (ERIS) reported revenue ₹893 Cr and net profit ₹187 Cr — revenue +12.6% YoY. Also explore ERIS share price history to track price trends across different timeframes.

ERIS Quarterly Results — Revenue, Profit & EPS Highlights

Eris Lifesciences latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. View ERIS 52-week high low for the annual high/low range and current price position.

  • Revenue of ₹893 Cr in Sept 2026 (+18.3% vs Mar 2026, +12.6% vs Sept 2025)
  • Net Profit of ₹187 Cr in Sept 2026 (-33.0% vs Mar 2026, +38.5% vs Sept 2025)
  • EBITDA of ₹273 Cr in Sept 2026 (+1.1% vs Mar 2026)
  • Operating Margin of 30.0% in Sept 2026 (-6.0pp vs Mar 2026)
  • Earnings Per Share of ₹13.26 in Sept 2026 (-35.6% vs Mar 2026)

Eris Lifesciences Quarterly Results — Revenue, EBITDA, Net Profit & EPS

ERIS quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2026 Mar 2026 Jun 2026 Sept 2025 Mar 2025 QoQ YoY
Revenue (₹ Cr) 893 755 871 793 711 18.3% 12.6%
Net Profit (₹ Cr) 187 279 143 135 102 - -
EBITDA (₹ Cr) 273 270 294 289 258 - -
EPS (₹) 13.26 20.60 10.28 8.82 6.90 - -
Operating Margin (%) 30.0% 36.0% 34.0% 36.0% 36.0% - -

ERIS Share Price Trend — 1-Year Movement Across Quarterly Results

Eris Lifesciences 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit Eris Lifesciences share price today.

Profitability Ratios

Profit Margin 20.9%
EBITDA Margin 30.6%
Operating Margin 30.0%
ROE (Annual) 19.2%

Balance Sheet Highlights

Total Assets ₹7,366 Cr
Total Equity ₹3,896 Cr
Current Assets ₹ Cr
Current Liabilities ₹1,393 Cr

Cash Flow Analysis

Operating Cash Flow ₹538 Cr
Investing Cash Flow ₹-370 Cr
Financing Cash Flow ₹-314 Cr
Net Cash Flow ₹-145 Cr

Current Market Data

Current Price ₹1329.00
Exchange NSE
Last Updated Nov 19, 2026

ERIS vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Eris Lifesciences latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2026
₹451,074.97 Cr 1900.0 16,617 1,995 +10.6% - 12.0% 228.9
Divis Laboratories
Sept 2026
₹294,139.19 Cr 11178.0 3,770 1,127 +26.3% - 29.9% 263.1
Torrent Pharmaceuti…
Mar 2026
₹188,719.51 Cr 4611.0 4,111 364 +27.7% +42.2% 8.9% 400.6
Apollo Hospitals
Sept 2026
₹126,832.45 Cr 8738.0 7,673 660 +15.2% - 8.6% 199.4
Laurus Labs
Sept 2026
₹125,946.78 Cr 2306.0 2,219 436 +21.7% - 19.6% 282.3
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores